In the course of our study, the ovarian cancer gene panel consisted of the five core genes (BRCA1, BRCA2, BRIP1, RAD51C and RAD51D), and it is likely that the gene panel will be expanded with other cancer genes, such as PALB2, in the near future. This evidence concerns the gene RAD51D and ovarian carcinoma.